| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,904 |
2,145 |
$116K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,461 |
1,278 |
$68K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
176 |
154 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
192 |
175 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
210 |
174 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
211 |
148 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
150 |
134 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
58 |
55 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
35 |
29 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
46 |
43 |
$892.58 |
| S8301 |
Infection control supplies, not otherwise specified |
29 |
26 |
$627.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
16 |
$513.30 |
| 87899 |
|
204 |
171 |
$323.33 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
14 |
12 |
$258.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
137 |
118 |
$76.32 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
13 |
12 |
$13.92 |